One of the more exciting stem cell biotechs out there today is Advanced Cell Technology (ACT). At this time ACT has the only two ES cell-based FDA-approved clinical trials ongoing and so far they have looked quite promising in terms of preliminary safety data. However, ACT has much more in the pipeline including potentially iPS […]
Interview with Gary Rabin of Advanced Cell Technology (ACT) Read More »
To blog or not to blog? Sometimes that is the question and a tough one. Keep going or shut it down? Let’s say that you are a blogger and scientist. I am one of those people wearing both of those hats. A sexy paper comes out in your field. It’s all over the Internet and
To blog or not to blog about sexy, but crappy paper from Dr. Famous? Read More »
Dr. Steven Victor, CEO of Intellicell, seems to have made two comments on a recent blog post I did on stem cell sports medicine (see below). Victor and Intellicell received a warning letter from the FDA in March 2012 with the FDA. I’m not aware of Intellicell publicly addressing the FDA issues. If you have, Intellicell, please
Dr. Steven Victor of Intellicell Comments on its Stem Cell Treatments Read More »
Two emerging acronyms in the for-profit stem cell world that remain unknown to most academic stem cell scientists, but that are generating the most buzz are: SVF and CAL. These are two fat acronyms. What? These acronyms relate to adipose (fat) stem cell-based procedures. SVF stands for “stromal vascular fraction”. SVF is, for lack of
SVF & CAL are two fat stem cell acronyms generating a lot of buzz Read More »
Below are links to specific court documents and filings in stem cell-related legal proceedings. (I’ve also placed in parentheses links to my posts/analysis on these). Enjoy, especially you lawyers and investors. It’s a work in progress so expect more cases and documents to appear. In fact, if you have suggested additions please add them (plus
Your stem cell legal documents hub Read More »
Is this a “good” stem cell blog post to write as I gobble down my lunch in between working on grants….hmm, maybe not. Too late! Stem cells are hot all around the globe, but they are particularly scorching hot in certain countries such as the Philippines. There are an increasing number of news articles on
Please pass on bull testicles Soup No. 5 & on stem cell Soup No. 7 Read More »
The Korean-based stem cell biotech, RNL Bio, which also does business in the U.S. as RNL Bio and Human Biostar Inc, reportedly (seems to be a press release, PR) has filed an investigational new drug (IND) application with the Korean FDA (KFDA). The purpose of the application is to test the efficacy of autologous adult stem cells
I requested of Celltex a copy of the email/letter that they recently sent to their patients. They kindly provided me a copy, which you can read here (snap shot of beginning is above). Thank you, Celltex! I also asked Celltex some questions regarding their plan to start having patients treated in Mexico. Unfortunately, they have
Celltex on the move: full copy of letter to patients, new slogan, and new video Read More »
Every year around this time I put my “best of” the year in stem cells including awards such as my Stem Cell Person of the Year Award. For example here are the 2011 awards. This year I’m also trying with difficult to decide on what was the craziest thing for stem cells that happened in
What was the strangest event for stem cells in 2012? Pick from top 5 in poll Read More »
Every now and then a paper on stem cells lands many international headlines and also captures people’s imaginations. This seems to be the case for the recent urine stem cell paper from a team in China, which has made huge headlines. In addition to mainstream media, the paper was covered in Wired here and also by one
Why did urine stem cell paper create global media sensation? Read More »